Product Information
- Biil-284
- Carbamic acid, N-[[4-[[3-[[4-[1-(4-hydroxyphenyl)-1-methylethyl]phenoxy]methyl]phenyl]methoxy]phenyl]iminomethyl]-, ethyl ester
- Carbamic acid, [[4-[[3-[[4-[1-(4-hydroxyphenyl)-1-methylethyl]phenoxy]methyl]phenyl]methoxy]phenyl]iminomethyl]-, ethyl ester
- ethyl {(E)-[(4-{[3-({4-[2-(4-hydroxyphenyl)propan-2-yl]phenoxy}methyl)benzyl]oxy}phenyl)amino]methylidene}carbamate - ethane (1:1)
Amelubant is a covalent leukotriene receptor antagonist that inhibits the binding of leukotrienes to their receptors. It is used for the treatment of bowel disease, such as inflammatory bowel disease. Amelubant also has affinity ligands and is active against eosinophil cationic protein. This drug has a degradable side chain and does not have an active metabolite. It binds to the leukotriene receptor and prevents it from activating, thereby inhibiting the release of pro-inflammatory mediators. Amelubant has been shown to be effective in clinical trials for the treatment of inflammatory bowel disease, with no major adverse effects.
Chemical properties
Technical inquiry about: 3D-WNA73524 Amelubant
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
